Effects of swallowing therapy for dysphagia on exacerbations of Chronic obstructive pulmonary disease
Recruiting
- Conditions
- Chronic bronchitisemphysema10024967
- Registration Number
- NL-OMON50180
- Lead Sponsor
- Maasstadziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
In order to be eligible to participate in this study, a subject must meet all
of the following criteria:
• COPD gold 2,3,4 with a Pulmonary Function Testing not older than 12 months
• At least 2 proven moderate or severe COPD exacerbation in the last 2 years
Exclusion Criteria
other lungdisease
active exacerbation COPD
reduced learning because of congnitive impairment
recent speech therapy (< 2 years)
other cause for dysphagia
Radiation of the mouth and throat area
Operation of the mouth and throat area
severe language barrier
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome measure is the number of moderate to severe exacerbations<br /><br>over a period of 12 months after allocation to treatment or control group. An<br /><br>exacerbation is defined as moderate if treatment with antibiotics or<br /><br>corticosteroid is initiated or dosage increase should be given. An exacerbation<br /><br>is defined as severe if a patient had to be hospitalized because of the<br /><br>exacerbation or dies.</p><br>
- Secondary Outcome Measures
Name Time Method <p>The secondary outcome measure is patient swallowing satisfaction measured by<br /><br>the VAS (visual analog scale) and the dysphagia disability index. These are<br /><br>evaluated at baseline and after 12 months</p><br>